Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease

Abroad (travel likely)Recruiting

Conditions

Extramedullary Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Gobroad Boren Hospital, Beijing, China
Contact: Study coordinator (Wei Chen) · chenwei@gobroadhealthcare.com · 008615801145177
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, China
Contact: Study coordinator (Gang An, PhD&MD) · angang@ihcams.ac.cn · 008613502181109

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Multiple Myeloma · Primary Plasma Cell Leukemia · Extramedullary Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Changzhou, China · Nanjing, China

European Myeloma Network (EMN) Sample Project

Multiple Myeloma · Smoldering Multiple Myeloma · Plasma Cell Leukemia

Abroad (travel likely)Recruiting

Melbourne, Australia · Linz, Austria

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

Extramedullary Disease in Multiple Myeloma · Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States